The first patient in the UK has been treated by the NHS with CSL Behring’s haemophilia B gene therapy Hemgenix (etranacogene ...

Sanofi and Regeneron’s Dupixent (dupilumab) has been approved by the US Food and Drug Administration (FDA) to treat bullous ...

Instead, identifying early-stage individuals necessitates biomarker-based screening, which adds layers of complexity to an ...

Explore key insights from some of May’s top healthcare conferences, covering patient engagement, health equity, co-creation, ...